SBWire

ProLung, Inc., ("ProLung" or the "Company") the world leader in innovative predictive analytics technology and non-invasive tests for the risk stratification of lung cancer, announces that the company has promoted Andy C. Robertson to Chief Marketing Officer.

Cancer vaccines are being developed as a method of preventing certain types of cancer, and as therapeutic treatments to treat existing cancers across a range of indications in oncology, either as stand-alone therapies or in combination with traditional cancer therapeutics such as chemotherapy and surgery. The high mortality rate associated with cancer and its resistance to conventional treatments such as radiation and chemotherapy has led to the investigation of a variety of anti-cancer immunotherapies, which have a lower toxicity associated with their use than traditional chemotherapies.

BriaCell Therapeutics Corp.("BriaCell"), an immuno-oncology focused biotechnology company with a proprietary targeted immunotherapy technology, is pleased to announce the opening of a new clinical site, Jefferson Breast Care Center in Philadelphia, PA, and the appointment of Dr. Saveri Bhattacharya, a board certified medical oncologist, as the clinical site's principal investigator. Dr. Bhattacharya will work closely with Cancer Insight, LLC., BriaCell's contract research organization, to manage the clinical and regulatory aspects of the clinical trial on behalf of BriaCell.

Anthony B. Miller MD, a longtime advisor to the World Health Organization and senior advisor to Environmental Health Trust (EHT) has issued a statement that the recently released findings from the $25M NIH/NIEHS National Toxicology Program (NTP) cell phone radiofrequency radiation carcinogenicity studies combined with human epidemiology studies "conclusively confirms that radiofrequency radiation is a category 1 human carcinogen." EHT is a scientific think tank focused on preventable environmental health risks and will be publishing a series of expert reactions to the NTP technical reports this week.

The National Toxicology Program (NTP) division of the National Institutes of Environmental Health Sciences (NIEHS) is releasing the full results of its multi-year study on mice and rats exposed to cell phone radiation today at noon EST.

Recently, the Lauren Ashtyn Collection launched a number of charitable and promotional initiatives on its website to fight breast cancer. Users and customers were offered prizes as incentives to discuss breast cancer experiences and the firm also donated a share of its sales revenue to the Susan G. Komen South Carolina.

New Jersey drivers who are looking for a way to start their year off by giving back to the community are encouraged to contact American Children's Society, Inc. to learn more about how they can turn an old vehicle into a way to help children suffering from cancer and other life-threatening illnesses.

TriForce CrossFit is officially opening its doors on Thursday, January 4th and welcoming anyone in the community to stop by and help row for cancer. For every 1k rowed during the grand opening between 9 a.m. and 8 p.m. $1 will be donated to Lynch Syndrome International toward helping to fight cancer.

CEL-SCI Corporation announced today that healthcare information technology executive Robert Watson has joined the Company's Board of Directors.

Top line results may soon be in at CEL-SCI, which concluded patient enrollment and dosing in the world's largest Phase III trial in the treatment of head and neck cancer. Between 2011 and 2016, 928 patients were enrolled and treated. According to the study's protocol, the effectiveness of CEL-SCI's drug in prolonging life can only be judged after 298 of the enrolled patients have died, since the FDA wants to see survival benefit. The number of deaths, or 'events', as they are termed in clinical trials, is unfortunately how and when the primary endpoint of most cancer studies are determined.

CEL-SCI Corporation announced today that no further patient enrollment is required in the pivotal Phase 3 head and neck cancer study of its investigational immunotherapy Multikine* (Leukocyte Interleukin, Injection). The accrual and treatment phases of this Phase 3 study are complete. All of the 928 enrolled patients in the study are being followed-up as required by the study protocol.

From the perspective of a stage IV cancer survivor and his caregiver, this is a detailed self-help journal on how to live calmly with cancer by using mindfulness and meditation. Married couple Tamara Green and David Dachinger have released an inspiring book documenting how they found inner peace in spite of their many challenges during David's diagnosis and treatment for metastatic cancer. The book provides quick and easy mindfulness tools and powerful meditations that help ease depression, anxiety and overwhelm.

This Christmas is unlike any previous one for LANGRIA. The furniture brand wants to give back and donate to Children's Cancer Research Fund to put a smile on kid's that are affected by any form of childhood cancer.

ImageFIRST, a provider of medical scrubs and uniforms in Cedar Rapids, IA, and throughout the continental United States and Puerto Rico, promoted breast cancer awareness during the month of October. At ImageFIRST's Los Angeles and San Francisco locations, associates showed their support for Breast Cancer Awareness Month a number of different ways.

Throughout the month of October, associates at several ImageFIRST branches showed their support for Breast Cancer Awareness Month in a variety of ways. ImageFIRST is a provider of medical laundry services in Cleveland, OH and across the continental United States and Puerto Rico.

Ulterra Drilling Technologies is a Fort Worth based PDC Bit Company known for their iconic teal bits. For the past 4 years, Ulterra has been committed to spreading awareness within the oilfield by collaborating with the organization Saving True Pairs based in Midland, TX. Their mission is to raise awareness of women's health issues and foster educational and service initiatives that positively embrace women's health. In Midland County alone 4 out of 5 women over 40 do not get mammograms. This is a big concern and the reasoning behind the organization's motivation to raise funds and awareness.

BriaCell Therapeutics Corp. ("BriaCell" or the "Company"), an immuno-oncology focused biotechnology company with a proprietary vaccine technology, today released a clinical update on its ongoing Phase I/IIa study of its lead vaccine candidate, BriaVax™, in advanced breast cancer patients.

Homeowners who are in need of reputable electricians in King of Prussia and love to give to a great cause are encouraged to contact Wes Carver Electric for all of their electric and knob and tube lighting needs in the Ambler, PA area.

Al Helou International Hospital of Gaza, Palestine has announced that it is now seeking support and raising funds on the crowdfunding platform of Indiegogo for the Al Helou Cancer Center. Gaza is one of the most troubled region in not only the Middle East but also around the world and unfortunately, it has the highest cancer rate in the world. More alarming is that rate by which the cancer is increasing and it is 30 percent per year. This crowdfunding campaign will help these people who cannot afford quality healthcare and everyone is being welcomed to help this initiative.

BriaCell Therapeutics Corp ("BriaCell" or the "Company"), an immuno-oncology focused biotechnology company with a proprietary vaccine technology, announced today that the FDA has approved the roll-over combination study of BriaVax™ with pembrolizumab Keytruda; manufactured by Merck & Co., Inc. or ipilimumab Yervoy; manufactured by Bristol-Myers Squibb Company for patients previously treated with BriaVax™ from the ongoing Phase I/IIa Clinical Trial in Advanced Breast Cancer.

Award-winning photographer Roger Ridpath announced today the donation of a limited edition print from his Kansas City Illuminated Series No. 1.,"Pamona in Pink." The print is the very first in a series focused on his hometown, Kansas City. "Pomona in Pink" was specifically created to raise awareness for breast cancer. The donated print will be auctioned at the Howl at the Moon & Open Arms Breast Cancer Outreach Fund event Friday, October 6, 2017.

EEC Biotech is proud to announce that we will host our second international SPDT conference in Guangzhou - "SPDT 4 LIFE International Conference - Holistic Anti-Cancer Therapies".

Local residents who are looking to ditch their old clunker are turning to a surprising source to donate a car in NJ: the American Children's Society, Inc. Residents who want to see their old car go to a good cause are donating to the American Children's Society, Inc. because they know that their old vehicle will be used to help children suffering from childhood cancer.

SPDT 4 Life is a leader in the field of cancer diagnosis and treatment, combining the best of traditional medicine and protocols with the latest research and proven holistic and alternative treatments. Focusing on using Sono Photo Dynamic Therapy (SPDT), the center's highly experienced medical team combines all of these treatments, its own extensive knowledge, and the most recent advances in cancer research to create personalized cancer treatment programs designed to meet the unique and specific needs of each of its patients.

ImageFIRST, a medical linen and laundry service provider in the United States and Puerto Rico, partnered with Alex's Lemonade Stand Foundation, an organization that raises funds towards curing childhood cancer. ImageFIRST Los Angeles hosted their own Alex's Lemonade Stand at the company's plant site in Gardena from June 5th until June 9th during the annual Alex's Lemonade Days.